Creo Medical Limited
USPTO PatentsView assignee record - 97 granted patents across 18 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Creo ranks #3,728 of 49,997 tracked US assignees by granted-patent volume, with 97 patents across 18 technology areas.
- #3,728
- of 49,997 US assignees by volume
- Top 8%
- by Innovation Score (53.9/100)
- 18.3
- avg claims per patent
- +200%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R3728 · Foreign Corporation #3,728 · 97 grants
GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 97 grants
- TOP-DECILE #3,728/49,997
- PHOTO-FINISH Arizona Board of…
- CPC-FOCUS A61B · 18 areas
- INNOV-PAR 53.9/100
- CLAIMS-RICH 18.3 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +200% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Arizona Board of Regents on Behalf of Northern Arizona University (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Creo’s 53.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Creo
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- CalAmp · near
CalAmp · near
54 score
- Creo Medical · this assignee
Creo Medical · this assignee
54 score
- Hisense USA · near
Hisense USA · near
54 score
- Pentair Water Pool… · near
Pentair Water Pool… · near
54 score
- Chang Gung University · near
Chang Gung University · near
54 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Creo's Innovation Score is 53.9/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Creo?
Each dot is one of Creo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Creo’s own 18.3 claims/patent is ABOVE the 6.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Creo's grants concentrate
Creo Medical Limited is a focused PatentsView assignee: 18 CPC subclasses with 95.9% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (18 grants) versus a trough of 3 in 2017. By volume, Creo sits between Arizona Board of Regents on Behalf of Northern Arizona University and Dynasty Footwear, Ltd..
Creo's three-year grant acceleration
From 2019–2021 to 2022–2024, Creo Medical Limited moved from 26 to 47 grants (1.81x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Creo's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Arizona Board of…
Arizona Board of Regents on Behalf of Northern Arizona University
97 patents
- Arlo
Arlo Technologies, Inc.
97 patents
- Bulgari S P A
Bulgari S.P.A.
97 patents
- Berlin Packaging
Berlin Packaging, LLC
97 patents
- Carefusion 2200
CareFusion 2200, Inc.
97 patents
- Dongguan Jiasheng…
Dongguan Jiasheng Lighting Technology Co., Ltd.
97 patents
- DSP Group
DSP Group Ltd.
97 patents
- Dynasty Footwear
Dynasty Footwear, Ltd.
97 patents
- Creo Medical ◀
Creo Medical Limited
97 patents
What this shows Creo holds 97 patents at rank #3,727, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Creo
By rank, the assignees closest to #3,727 in granted patent volume.
- Arizona Board of Regents on Behalf of Northern Arizona University #3,723 · 97 patents
- Arlo Technologies, Inc. #3,724 · 97 patents
- Bulgari S.P.A. #3,725 · 97 patents
- Berlin Packaging, LLC #3,726 · 97 patents
- CareFusion 2200, Inc. #3,728 · 97 patents
- Dongguan Jiasheng Lighting Technology Co., Ltd. #3,729 · 97 patents
- DSP Group Ltd. #3,730 · 97 patents
- Dynasty Footwear, Ltd. #3,731 · 97 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Creo's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Creo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Creo ranks #197 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (54 here).
Similar claim depth
Nearest assignees by average claims per patent (18.3 here).
Creo's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
54 Top 8% higher than 92% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 4.1% |
| 2016 | 5 | 5.2% |
| 2017 | 3 | 3.1% |
| 2018 | 3 | 3.1% |
| 2019 | 7 | 7.2% |
| 2020 | 7 | 7.2% |
| 2021 | 12 | 12.4% |
| 2022 | 12 | 12.4% |
| 2023 | 18 | 18.6% |
| 2024 | 17 | 17.5% |
| 2025partial year | 9 | 9.3% |
Which technologies does Creo Medical Limited patent most?
Top 15 of 18 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Creo Medical Limited's patent record in context - here's where to go next.
- Creo Medical Limited's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 95.9% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #3,728 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Creo Medical Limited against Arizona Board of Regents on Behalf of Northern Arizona University, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 53.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.